Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck

Eur J Cancer. 1992;28(2-3):484-5. doi: 10.1016/s0959-8049(05)80083-8.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / secondary
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Drug Evaluation
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Hematologic Diseases / chemically induced
  • Humans
  • Male
  • Middle Aged

Substances

  • Doxorubicin
  • pirarubicin